0001209191-18-004284.txt : 20180118
0001209191-18-004284.hdr.sgml : 20180118
20180118165219
ACCESSION NUMBER: 0001209191-18-004284
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180116
FILED AS OF DATE: 20180118
DATE AS OF CHANGE: 20180118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scribner Matt
CENTRAL INDEX KEY: 0001596087
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36309
FILM NUMBER: 18534465
MAIL ADDRESS:
STREET 1: 326 BOLLAY DRIVE
CITY: GOLETA
STATE: CA
ZIP: 93117
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inogen Inc
CENTRAL INDEX KEY: 0001294133
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 326 BOLLAY DRIVE
CITY: GOLETA
STATE: CA
ZIP: 93117
BUSINESS PHONE: 805-562-0500
MAIL ADDRESS:
STREET 1: 326 BOLLAY DRIVE
CITY: GOLETA
STATE: CA
ZIP: 93117
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-16
0
0001294133
Inogen Inc
INGN
0001596087
Scribner Matt
C/O INOGEN, INC.
326 BOLLAY DRIVE
GOLETA
CA
93117
0
1
0
0
EVP, Operations
Common Stock
2018-01-16
4
M
0
2500
0.81
A
7297
D
Common Stock
2018-01-16
4
S
0
2500
116.1672
D
4797
D
Stock Option (right to buy)
0.81
2018-01-16
4
M
0
2500
0.00
D
2022-03-28
Common Stock
2500
15183
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016.
Represents the weighted average share price of an aggregate total of 2,500 shares sold in the price range of $115.68 to $116.57 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is April 1, 2012.
/s/ Alison Bauerlein, as Attorney-in-Fact
2018-01-17